Ad is loading...
ADCT
Price
$1.97
Change
+$0.03 (+1.55%)
Updated
Nov 22, 03:13 PM (EDT)
111 days until earnings call
MLYS
Price
$12.45
Change
+$0.58 (+4.89%)
Updated
Nov 22, 03:30 PM (EDT)
Ad is loading...

ADCT vs MLYS

Header iconADCT vs MLYS Comparison
Open Charts ADCT vs MLYSBanner chart's image
ADC Therapeutics SA
Price$1.97
Change+$0.03 (+1.55%)
Volume$200
CapitalizationN/A
Mineralys Therapeutics
Price$12.45
Change+$0.58 (+4.89%)
Volume$300
CapitalizationN/A
ADCT vs MLYS Comparison Chart
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ADCT vs. MLYS commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and MLYS is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (ADCT: $1.94 vs. MLYS: $11.87)
Brand notoriety: ADCT and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 111% vs. MLYS: 128%
Market capitalization -- ADCT: $191.45M vs. MLYS: $590.75M
ADCT [@Biotechnology] is valued at $191.45M. MLYS’s [@Biotechnology] market capitalization is $590.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, MLYS is a better buy in the long-term than ADCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while MLYS’s TA Score has 5 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 5 bearish.
  • MLYS’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, both ADCT and MLYS are a bad buy in the short-term.

Price Growth

ADCT (@Biotechnology) experienced а -26.79% price change this week, while MLYS (@Biotechnology) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

ADCT is expected to report earnings on Mar 13, 2025.

MLYS is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($591M) has a higher market cap than ADCT($191M). MLYS YTD gains are higher at: 38.023 vs. ADCT (16.867). ADCT has higher annual earnings (EBITDA): -110.43M vs. MLYS (-168.35M). ADCT (274M) and MLYS (264M) have equal amount of cash in the bank . ADCT has higher revenues than MLYS: ADCT (70.7M) vs MLYS (0).
ADCTMLYSADCT / MLYS
Capitalization191M591M32%
EBITDA-110.43M-168.35M66%
Gain YTD16.86738.02344%
P/E RatioN/AN/A-
Revenue70.7M0-
Total Cash274M264M104%
Total Debt125MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ADCTMLYS
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 17 days ago
89%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYSVX213.043.81
+1.82%
Rydex S&P SmallCap 600 Pure Value A
PMEGX70.961.14
+1.63%
T. Rowe Price Instl Mid-Cap Equity Gr
NQGCX35.030.28
+0.81%
Nuveen Global Equity Income C
ETCHX30.470.20
+0.66%
Eventide Healthcare & Life Sciences C
AIOCX8.380.04
+0.48%
American Century International Opps C

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CCCC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
-2.02%
CCCC - ADCT
45%
Loosely correlated
-0.99%
STTK - ADCT
43%
Loosely correlated
-9.01%
PRME - ADCT
43%
Loosely correlated
-0.67%
ACAD - ADCT
40%
Loosely correlated
-0.55%
MLYS - ADCT
40%
Loosely correlated
-5.79%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with RXRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-5.79%
RXRX - MLYS
40%
Loosely correlated
-4.80%
ADCT - MLYS
40%
Loosely correlated
-2.02%
PLRX - MLYS
40%
Loosely correlated
+0.94%
PRME - MLYS
40%
Loosely correlated
-0.67%
LYEL - MLYS
39%
Loosely correlated
-11.01%
More